News & Updates
Filter by Specialty:
Prophylactic aflibercept reduces vision-threatening complications without gains in visual acuity
Treatment with intravitreal aflibercept in patients with nonproliferative diabetic retinopathy but without centre-involved diabetic macular edema appears to slow disease progression and reduce the risk of developing vision-threatening complications but fall short of improving visual acuity, according to a study.
Prophylactic aflibercept reduces vision-threatening complications without gains in visual acuity
15 Feb 2023
Outpatient oritavancin bests inpatient SoC in acute uncomplicated cellulitis
Outpatient oritavancin therapy appears to be more effective than inpatient standard-of-care (SoC) in reducing 30-day hospital readmissions or admissions among individuals with acute uncomplicated cellulitis, a recent study has shown.
Outpatient oritavancin bests inpatient SoC in acute uncomplicated cellulitis
15 Feb 2023
High-intensity exercise improves BP, body composition of hypertensive patients
The inclusion of a moderate- (MT) or high-intensity training (HIT) program as adjuvant therapy in hypertensive patients appears beneficial in reducing certain cardiovascular risks, but only HIT is effective at lowering blood pressure (BP) and losing body mass and fat, reports a study.
High-intensity exercise improves BP, body composition of hypertensive patients
15 Feb 2023
Childhood asthma, T1D, IBD: Do they have shared mechanisms?
Children diagnosed with asthma between ages 5 and 7 years may have an increased risk of developing type 1 diabetes (T1D) and inflammatory bowel diseases (IBD; Crohn’s disease and ulcerative colitis), a Danish nationwide registry study suggests.
Childhood asthma, T1D, IBD: Do they have shared mechanisms?
15 Feb 2023
Aspirin as good as heparin for thromboprophylaxis in patients with fractures
Thromboprophylaxis with aspirin in patients with extremity fractures appears to prevent death and lower the incidences of deep-vein thrombosis and pulmonary embolism without any significant differences as compared with thromboprophylaxis with low-molecular-weight heparin, according to a study.